Pertussis vaccine (ILiAD/INSERM)
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NamePertussis vaccine (ILiAD/INSERM)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A
Develop Information
Active CompaniesIliad Biotechnologies
Inactive CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979National Institute Of Allergy And Infectious Diseases (Niaid)
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A